Member Info for bighammer

Ha ha , Stock you are right and like you say very hard to do at times as we all think we are great traders and right all the time, admitting we are not is hard to do. Lets hope we dont have to do it here for a while

What a great , well put together post Rodney, i could nt agree with your thoughts on Cheek . People wanted rid of RF and now they are saying they want it back . With this new deal we have funding for at least 12 months, enough for the FDA trials and possibly application AND shareholders have the chance to average down , personally from 39p to about 13p. Only Profit , With worldwide sales for the 2 tests at about £200m plus for anyone to say this will could never get above 15p are talking tripe, i am not saying it will but i would DEFINATELY not bet against it.

Not had nothing from Barcs yet, any other way to subscribe for the OO?

I think it is the same aS DIVIS, you have to be holding on the day.

With such a heavy discount the sp usually returns to pre placement sp, which in this case equates to 100% profit, take into account the run up to and even NICE news it could be a lot higher, nailed on , no but a very good chance . The best way to ruduce your average

Thats a good sign Joey, is that for your allocation?

1DR, spot on , you can apply for your equivilant holding and apply for as many extra as you want , if it is under applied you may well get all your extras, or if it is over subscribed then a % will be worked out for your allocation , will look to treble my holding if possible just need to transfer funds .

Bang on System.

Quick question, with the OO will we get share certs or can you buy through your deales to keep them in ISA?

I like the fact we have gone for £6m raise and the shareholders have the chance to participate but the discount is criminal , but the position we are in it is also understandable . I will be looking to take as much as i can for 2 reasons, cash is now no longer an issue for us to proceed as long as we raise the amount, and the second is to try and keep as many shares in private hands.

There are some who have said no II would invest here the way we are financially , and to a point they are right , but on the other hand we are a perfect fit for an II.

Why, because we are no longer just an R and D company as we now have world class products , 1 already on the shelf being sold , all be it slowly, and 1 hopefully in July fully on the market , with timelines established.

From the presentation we know its 12 months for data gathering in the US, 2 years for NICE but with these combined that could well be reduced . FDA website states $500k cost for De Novo application with 150 days timescale for news. With the partner news in the US , will we fund the test and machines or supply at cost as they will be sold to parents i assume so just pay for data gathering????????.

£2m for US , £5m for running costs for the next 12 months, plus £2m just in case we run over = £9m

£3m placing now at 3.5p to give us stability , and then when the sp gets to 10p which it would easily with conformation in July then £4m to the II at 5p giving them 50% discount , BUT also £2m OO to all shareholders , rewarding them also .?????

Looks like Tiger has flipped the coin and it came up heads again.

All the best Tiger , we are all out to make money.

Ahhhh bless him he is trying to save us.

Ha ha Just admit it Tiger you bought in hoping to be able to pump it up to grab a quick 20% profit and it has nt worked out and now you are all doom and gloom . THERE WAS NEVER going to be news from NICE until July and you so called research and contacts did not work out.

£5m sounds a lot and 12 months does nt seem long but the stroke test market is about £150m world wide so only 3% then sales from hearing test and grants etc so definately do able as long as in July we get full approval which seems likely

Its interesting when you look at the list Eureka posted yesterday that the only real negative is financing , BUT that far outways all the positives currently . How long would it take to get to sales being the same as outgoings , 12 months i think roughly , so if we could get £5m deal then this could turn round very quickly. if the stroke test IS nailed on then a deal should be quite easy with a discount of about 30% ish . Although an FDA approval would be great it is not the holy grail as it is about 1 third of potential worldwide sales for the hearing tests and we are already getting sales although slowly. As an R and D company we are on the cusp , but like most this is where we could fail but i think in Cheek we have a very real chance of progress , unless something a little underhand pops up . These tests have a potential of multi million pound incomes per annum so never rule anything out.

Good summary Eureka01, just to add if /when we get full approval for the stroke test this could make a huge difference to the roll out world wide as NICE carries a lot of credence and would speed up any use for other health care around the world.

De Novo route is quicker as well , 150 days from full application , so if we look at 12 months research then 6 months ish for news.

Roger , from memory FDA application is about £500k for De Novo , much cheaper than other routes , as for trials , dont know.